Topic: Drugs/Marijuana

    (U//FOUO) DEA Emerging Threats Reports 2016

    The Special Testing and Research Laboratory’s Emerging Trends Program compiled the data for this report through a query of archived seizure and analysis information from drug evidence analyzed by the Drug Enforcement Administration’s laboratory system. This data is representative of drug evidence seized and analyzed in the date ranges annotated. This is not a comprehensive list of all new psychoactive substances and is not representative of all evidence analyzed by DEA. This data is a quarterly snapshot of the new psychoactive substance market in the United States.

    (U//FOUO) Northwest High Intensity Drug Trafficking Area Threat Assessment and Strategy For Program Year 2018

    The opioid epidemic continues to dominate headlines within the state and throughout the region. Powerful synthetic opioids, such as fentanyl and its derivatives, led to the overdose deaths of 70 individuals in Washington State during 2016 – more than twice the number of fentanyl-related deaths in the previous year. Although much of Washington’s focus is on curbing the opioid crisis, methamphetamine remains a critical threat in the Pacific Northwest. The regulation of recreational and medicinal marijuana continues to pose new challenges for law enforcement even as use of the drug in Washington State has been legal for several years.

    DEA Data Shows Drug Cartels Continue to “Operate and Profit” From Marijuana Sales in Legalized Markets

    A bulletin from the El Paso Intelligence Center (EPIC) released to law enforcement in February 2017 describes how Mexican transnational criminal organizations (TCOs) are continuing to exploit legalized markets for the sale and distribution of marijuana. In January 2016, EPIC produced a bulletin detailing how “data provided by the Drug Enforcement Administration (DEA) and open source reporting” indicated that Mexican TCOs had not been adversely affected by marijuana legalization in numerous markets, noting instead “that the effort of legalization had conversely brought new opportunities for illicit profits from marijuana sales.”

    (U//LES) EPIC Bulletin: Transnational Criminal Organizations (TCOs) Continue to Profit from Marijuana Sales in Legalized Markets

    In January 2016, EPIC published Intelligence Note 02303-16a, this product provided analysis of data provided by the Drug Enforcement Administration (DEA) and open source reporting that indicated Transnational Criminal Organizations (TCOs) continued to operate and profit from marijuana sales in legalized U.S. marijuana markets. EPIC research further showed that legalization of marijuana in some U.S. markets had not adversely impacted TCO profitability in marijuana markets, and that the effort of legalization had conversely brought new opportunities for illicit profits from marijuana sales. As of January 2017, EPIC research indicates that TCOs continue to exploit legalized marijuana markets in the United States.